| Literature DB >> 28084650 |
Giedre Grigelioniene1,2,3, Pasi I Nevalainen4, Monica Reyes1, Susanne Thiele1, Olta Tafaj1, Angelo Molinaro1, Rieko Takatani1, Marja Ala-Houhala5, Daniel Nilsson2,3,6, Jesper Eisfeldt2,6, Anna Lindstrand2,3, Marie-Laure Kottler7, Outi Mäkitie8,9, Harald Jüppner1,10.
Abstract
Pseudohypoparathyroidism type Ib (PHP1B) is characterized primarily by resistance to parathyroid hormone (PTH) and thus hypocalcemia and hyperphosphatemia, in most cases without evidence for Albright hereditary osteodystrophy (AHO). PHP1B is associated with epigenetic changes at one or several differentially-methylated regions (DMRs) within GNAS, which encodes the α-subunit of the stimulatory G protein (Gsα) and splice variants thereof. Heterozygous, maternally inherited STX16 or GNAS deletions leading to isolated loss-of-methylation (LOM) at exon A/B alone or at all maternal DMRs are the cause of autosomal dominant PHP1B (AD-PHP1B). In this study, we analyzed three affected individuals, the female proband and her two sons. All three revealed isolated LOM at GNAS exon A/B, whereas the proband's healthy maternal grandmother and uncle showed normal methylation at this locus. Haplotype analysis was consistent with linkage to the STX16/GNAS region, yet no deletion could be identified. Whole-genome sequencing of one of the patients revealed a large heterozygous inversion (1,882,433 bp). The centromeric breakpoint of the inversion is located 7,225 bp downstream of GNAS exon XL, but its DMR showed no methylation abnormality, raising the possibility that the inversion disrupts a regulatory element required only for establishing or maintaining exon A/B methylation. Because our three patients presented phenotypes consistent with PHP1B, and not with PHP1A, the Gsα promoter is probably unaffected by the inversion. Our findings expand the spectrum of genetic mutations that lead to LOM at exon A/B alone and thus biallelic expression of the transcript derived from this alternative first GNAS exon.Entities:
Keywords: DISORDERS OF CALCIUM/PHOSPHATE METABOLISM; EPIGENETICS; G protein; GNAS; PARATHYROID-RELATED DISORDERS
Mesh:
Substances:
Year: 2017 PMID: 28084650 PMCID: PMC5395346 DOI: 10.1002/jbmr.3083
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741